Generation of antigen-presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients

European Journal of Immunology
P FischL Kanz

Abstract

Peripheral blood CD34+ hematopoietic cells (PBPC) mediate hematopoietic reconstitution in cancer patients after autologous transplantation and can be expanded ex vivo in the presence of colony-stimulating factors. This study shows that functionally active antigen-presenting cells (APC) for soluble proteins are generated and expanded in these PBPC cultures. CD34+ cells were cultured ex vivo in medium containing stem cell factor, interleukin-1 beta (IL-1 beta), IL-3, IL-6, and erythropoietin (EPO). The cells from these cultures developed into very potent APC of tetanus toxoid and purified derivative of tuberculin for autologous T cells in vitro. The antigen-presenting capacity of these cell was maintained for at least 38 days of culture. These APC resembled immature cells of the myelomonocytic cell lineage by surface marker, immunocytochemistry and ultrastructural analysis. Such APC might be able to present antigens from certain tumors to the immune system.

References

Jan 21, 1992·International Journal of Cancer. Journal International Du Cancer·P G CoulieT Boon
Jan 1, 1992·The Journal of Experimental Medicine·N BhardwajA J Nisanian
Jan 1, 1991·Annual Review of Immunology·R M Steinman
Jan 1, 1991·Annual Review of Immunology·F M Brodsky, L E Guagliardi
Jul 1, 1994·The Journal of Experimental Medicine·N RomaniG Schuler
Jan 1, 1994·Annual Review of Immunology·T BoonA Van Pel
Aug 1, 1993·The Journal of Experimental Medicine·C Reis e SousaJ M Austyn
Jun 1, 1993·Immunology Today·D M Pardoll
Jan 1, 1993·Annual Review of Immunology·D Cournoyer, C T Caskey
Jan 1, 1993·Annual Review of Immunology·R N Germain, D H Margulies

❮ Previous
Next ❯

Citations

Apr 20, 2005·Cancer Immunology, Immunotherapy : CII·Frank GrünebachPeter Brossart
May 7, 1997·Transfusion Science·J Banchereau
Jan 1, 1997·Vox Sanguinis·M J Watts, D C Linch
Oct 24, 2001·Journal of Hematotherapy & Stem Cell Research·R M SymeS Glück
Jun 18, 1999·Annals of the New York Academy of Sciences·W BruggerL Kanz
Oct 18, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·A Nencioni, P Brossart
Jun 15, 2005·Seminars in Immunology·Jenny Valladeau, Sem Saeland
Sep 1, 1996·Blood Reviews·M J Alcorn, T L Holyoake
Mar 29, 2000·The British Journal of Dermatology·I KimberC E Griffiths
Nov 10, 2012·PloS One·Ayako MochizukiRyutaro Kamijo
Jan 16, 2009·American Journal of Reproductive Immunology : AJRI·Beata GrygielskaMaciej Kurpisz
Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A CurtiR M Lemoli
Sep 1, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·A EgestenT Persson
Sep 1, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P VengeA Trulson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.